Indaptus Therapeutics Statistics Share Statistics Indaptus Therapeutics has 572.66K
shares outstanding. The number of shares has increased by -0.76%
in one year.
Shares Outstanding 572.66K Shares Change (YoY) -0.76% Shares Change (QoQ) -0.86% Owned by Institutions (%) 4.56% Shares Floating 467.93K Failed to Deliver (FTD) Shares 29 FTD / Avg. Volume 0.01%
Short Selling Information The latest short interest is 18.67K, so 1.69% of the outstanding
shares have been sold short.
Short Interest 18.67K Short % of Shares Out 1.69% Short % of Float 1.94% Short Ratio (days to cover) 2.16
Valuation Ratios The PE ratio is -14.69 and the forward
PE ratio is -0.27.
Indaptus Therapeutics's PEG ratio is
1.17.
PE Ratio -14.69 Forward PE -0.27 PS Ratio 0 Forward PS n/a PB Ratio 55.92 P/FCF Ratio -17.9 PEG Ratio 1.17
Financial Ratio History Enterprise Valuation Currently the Enterprise Value (EV) is not available for Indaptus Therapeutics.
EV / Sales n/a EV / EBITDA n/a EV / EBIT n/a EV / FCF n/a
Financial Position The company has a current ratio of 1.95,
with a Debt / Equity ratio of 0.02.
Current Ratio 1.95 Quick Ratio 1.95 Debt / Equity 0.02 Debt / EBITDA -0.01 Debt / FCF -0.01 Interest Coverage 0
Financial Efficiency Return on Equity is n/a and Return on Invested Capital is n/a.
Return on Equity n/a Return on Assets n/a Return on Invested Capital n/a Revenue Per Employee n/a Profits Per Employee $-2.15M Employee Count 7 Asset Turnover 0 Inventory Turnover n/a
Taxes Income Tax n/a Effective Tax Rate 0%
Stock Price Statistics The stock price has increased by -92.83% in the
last 52 weeks. The beta is 1.13, so Indaptus Therapeutics's
price volatility has been higher than the market average.
Beta 1.13 52-Week Price Change -92.83% 50-Day Moving Average 8.78 200-Day Moving Average 16.7 Relative Strength Index (RSI) 19.54 Average Volume (20 Days) 235,494
Income Statement
Revenue n/a Gross Profit -735 Operating Income -15.37M Net Income -15.02M EBITDA -15.02M EBIT -15.02M Earnings Per Share (EPS) -1.61
Full Income Statement Balance Sheet The company has 5.79M in cash and 84.16K in
debt, giving a net cash position of 5.7M.
Cash & Cash Equivalents 5.79M Total Debt 84.16K Net Cash 5.7M Retained Earnings -60.44M Total Assets 6.84M Working Capital -2.1M
Full Balance Sheet Cash Flow In the last 12 months, operating cash flow was -12.32M
and capital expenditures 0, giving a free cash flow of -12.32M.
Operating Cash Flow -12.32M Capital Expenditures n/a Free Cash Flow -12.32M FCF Per Share -1.32
Full Cash Flow Statement Margins
Gross Margin n/a Operating Margin n/a Pretax Margin n/a Profit Margin n/a EBITDA Margin n/a EBIT Margin n/a FCF Margin n/a
Dividends & Yields INDP does not appear to pay any dividends at this time.
Dividend Per Share n/a Dividend Yield n/a Dividend Growth (YoY) n/a Payout Ratio n/a Earnings Yield n/a FCF Yield n/a
Dividend Details Analyst Forecast The average price target for INDP is $238,
which is 8078.7% higher than the current price. The consensus rating is "Buy".
Price Target $238 Price Target Difference 8078.7% Analyst Consensus Buy Analyst Count 2
Stock Forecasts Fair Value There are several formulas that can be used to estimate the
intrinsic value of a stock.
Lynch Fair Value n/a Lynch Upside n/a Graham Number n/a Graham Upside n/a
Stock Splits The last stock split was on Jun 27, 2025. It was a
backward
split with a ratio of 1:28.
Last Split Date Jun 27, 2025 Split Type backward Split Ratio 1:28
Scores Altman Z-Score -22.78 Piotroski F-Score 3
